MASTE 200

Products description: Unique Pharma - MASTE 200

This overview synthesizes information on Drostanolone enanthate, the active substance reportedly in Unique Pharma - MASTE 200, from a limited set of key scientific literature and reputable databases. The information presented aims to be current based on sources accessible and reviewed up to August 8, 2025. Medical knowledge and guidelines are constantly evolving; always consult primary sources and healthcare professionals for the absolute most current information.

Drostanolone enanthate is a synthetic anabolic-androgenic steroid (AAS), a derivative of dihydrotestosterone (DHT). It is known for its strong androgenic properties and moderate anabolic effects. The enanthate ester allows for a slow release of the active substance from the injection site, providing a prolonged effect [1, 3].

⚕️Established Medical Uses for Drostanolone Enanthate

While Drostanolone has a history of medical use, primarily in the treatment of breast cancer, its use has been largely replaced by other, more effective medications [4, 5]:

• In the past, drostanolone propionate was used for the palliative treatment of **inoperable breast cancer** in postmenopausal women.
• Today, its use in clinical medicine is very limited, and it is rarely, if ever, prescribed for therapeutic purposes [4].

🔬Mechanism of Action (Scientifically Described for Drostanolone Enanthate)

The primary mechanism of action for drostanolone enanthate involves its binding to androgen receptors and its anti-estrogenic properties [1, 2, 5]:

• Ester Cleavage and Drostanolone Release: After intramuscular injection, the enanthate ester is slowly hydrolyzed, releasing free drostanolone into the bloodstream. This slow release provides a prolonged effect, requiring less frequent injections.
• Androgen Receptor Binding: Drostanolone binds to and activates androgen receptors (ARs) in various tissues. This binding promotes protein synthesis and nitrogen retention, leading to anabolic effects.
• Lack of Aromatization: A key feature of drostanolone is that it is a DHT derivative and does not aromatize into estrogen. This means it does not cause estrogenic side effects like gynecomastia or water retention.

⚠️Safety and Adverse Effects (Balanced & Fact-Based for Drostanolone Enanthate)

The use of Drostanolone enanthate (the active substance in Unique Pharma - MASTE 200) is associated with a range of potential adverse effects, which are generally dose-dependent [1, 4]:

• Androgenic Effects: Due to its high androgenic nature, side effects such as acne, oily skin, accelerated male pattern baldness, and hirsutism (excessive body hair growth) are common. In women, virilization (e.g., deepening of the voice, clitoral enlargement) is a significant risk [4].
• Endocrine Disruption: Exogenous drostanolone strongly suppresses natural testosterone production, which can lead to testicular atrophy and impaired spermatogenesis in men.
• Cardiovascular Risks: It can negatively impact lipid profiles, lowering HDL ("good") cholesterol and increasing LDL ("bad") cholesterol, which increases the risk of cardiovascular disease.

💉Dosage and Administration (General Medical Context for Drostanolone Enanthate)

Drostanolone enanthate is administered via intramuscular injection. Due to its long-acting ester, it is typically injected less frequently than drostanolone propionate, often once or twice per week [1, 5]:

• Non-Medical Use: Dosages are highly variable and unregulated, based on anecdotal evidence from non-medical communities.
• Professional Monitoring: In a clinical setting, a healthcare professional would carefully determine dosage and duration, but this is absent in non-medical use, which increases the associated health risks.

📚References

1. Frontiers in Pharmacology. A comprehensive review of the clinical pharmacology of anabolic-androgenic steroids. Accessed August 8, 2025. https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2017.00900/full
2. Mediasphera.ru. Drostanolone and its use in oncology. Accessed August 8, 2025. https://www.mediasphera.ru/issues/khirurgiya-zhurnal-im-n-i-pirogova/2021/10/1002312072021101105
3. PubChem. Drostanolone Enanthate. National Center for Biotechnology Information. PubChem Compound Database. CID 2244. Accessed August 8, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/Drostanolone-Enanthate
4. Inchem.org. Drostanolone. Accessed August 8, 2025. https://www.inchem.org/documents/pims/pharm/pim901.htm
5. Chemical Book. Drostanolone Enanthate: Impact and Applications. Accessed August 8, 2025. https://www.chemicalbook.com/article/drostanolone-enanthate-impact-and-applications.htm

This information is not medical advice. Consult with a doctor to use this product.